MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MIR stock logo

MIR

Mirion Technologies, Inc.

$17
-0.26
 (-1.51%)
Exchange:  NYSE
Market Cap:  4.159B
Shares Outstanding:  95.125M
Delayed data
Calculate MIR Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Industrials
Industry:  Industrial – Machinery
   
CEO:  Thomas D. Logan
Full Time Employees:  2800
Address: 
1218 Menlo Drive
Atlanta
GA
30318
US
Website:  https://www.mirion.com
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion’s extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/04/29 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue800,900860,800925,400
Gross Profit356,500401,800438,600
EBITDA149,000179,000212,900
Operating Income-21,90024,80051,500
Net Income-96,900-36,10028,800

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets2,718,5002,636,0003,588,100
Total Liabilities1,168,5001,076,9001,671,200
Total Stockholders Equity1,484,5001,505,6001,866,400
Total Debt721,000719,900790,600
Cash and Cash Equivalents128,800175,200412,300

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow95,20099,100143,300
Capital Expenditure-37,100-48,800-36,400
Free Cash Flow58,10050,300106,900
Net Income-96,900-36,60028,800
Net Change in Cash55,50045,100239,600

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)1,307,921.279Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)1,309,813.298Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)1,308,867.289Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)441,479.476Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)442,118.114Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)441,798.795Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)205,152.137Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)211,331.040Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)208,241.589Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)546,670.744Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)547,461.549Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)547,066.147Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.800Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.810Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.790Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)3Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)3Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
860.8M  ?P/S
 (TTM)
: 
4.26
?Net Income
 (TTM)
: 
-36100000  ?P/E
 (TTM)
: 
166.49
?Enterprise Value
 (TTM)
: 
5.015B  ?EV/FCF
 (TTM)
: 
55.91
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.01  ?ROIC
 (TTM)
: 
0.01
?Net Debt
 (TTM)
: 
538.5M  ?Debt/Equity
 (TTM)
: 
0.67
?P/B
 (TTM)
: 
2.27  ?Current Ratio
 (TTM)
: 
3.19

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
28.33Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates MIR intrinsic value between $3.43 – $3.61 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about MIR valuation

Is Mirion Technologies, Inc. (MIR) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Mirion Technologies, Inc. (MIR) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MIR a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MIR trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MIR’s P/E ratio?

You can see MIR’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MIR?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MIR a good long-term investment?

Whether MIR fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

MIR

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-1.51
MARKETSnap

Trading Metrics:

Open: 17.39   Previous Close: 17.26
Day Low: 16.44   Day High: 17.61
Year Low: 16.43   Year High: 30.28
Price Avg 50: 18.79   Price Avg 200: 22.4
Volume: 2.025M   Average Volume: 4.426M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

A Look at Mirion Technologies Inc (MIR) After 5.8% Decline -- GF Value $13.12 vs Price $16.96
27-05-2026 20:51
A Look at Mirion Technologies Inc (MIR) After 5.8% Decline -- GF Value $13.12 vs Price $16.96
Is Mirion Technologies Inc (MIR) Overvalued After 4.2% Rally? GF Value Says Overvalued
22-05-2026 18:53
Is Mirion Technologies Inc (MIR) Overvalued After 4.2% Rally? GF Value Says Overvalued
Mirion Technologies, Inc. (MIR) Q1 2026 Earnings Call Transcript
29-04-2026 17:01
Mirion Technologies, Inc. (MIR) Q1 2026 Earnings Call Transcript
Mirion Technologies (MIR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
28-04-2026 21:01
Mirion Technologies (MIR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Mirion Technologies, Inc. (MIR) Q1 Earnings Meet Estimates
28-04-2026 20:01
Mirion Technologies, Inc. (MIR) Q1 Earnings Meet Estimates
Mirion Technologies, Inc. (MIR) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript
18-02-2026 17:15
Mirion Technologies, Inc. (MIR) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read